The sarcoglycan complex in limb-girdle muscular dystrophy.

The involvement of the sarcoglycan complex in the pathogenesis of muscular dystrophy is becoming increasingly clear. Sarcoglycan gene mutations lead to four forms of autosomal recessive limb-girdle muscular dystrophy. Recent progress has been made with the identification of novel mutations and their correlations with disease. Through this research, a better understanding the molecular pathogenesis of limb-girdle muscular dystrophy has been gained. Finally, animal models are now being used to study viral-mediated gene transfer for the future treatment of this disease.

[1]  J. R. Baker,et al.  Primary, Generalized Polymyopathy and Cardiac Necrosis in an Inbred Line of Syrian Hamsters , 1962 .

[2]  C. Jackson,et al.  Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease. , 1968, Pediatrics.

[3]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[4]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[5]  M. Pericak-Vance,et al.  Clinical and genetic investigation in autosomal dominant limb‐girdle muscular dystrophy , 1988, Neurology.

[6]  L. Kunkel,et al.  Dystrophin abnormalities in Duchenne/Becker muscular dystrophy , 1989, Neuron.

[7]  K. Campbell,et al.  Association of dystrophin and an integral membrane glycoprotein , 1989, Nature.

[8]  J. Ervasti,et al.  Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle , 1990, Nature.

[9]  S. Carpenter,et al.  Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions , 1990, Journal of the Neurological Sciences.

[10]  E. Ozawa,et al.  Glycoprotein complex anchoring dystrophin to sarcolemma. , 1990, Journal of biochemistry.

[11]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[12]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[13]  J. Beckmann,et al.  A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. , 1991, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[14]  J. Beckmann,et al.  Confirmation of linkage of limb-girdle muscular dystrophy, type 2, to chromosome 15. , 1992, Genomics.

[15]  M. Pericak-Vance,et al.  Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. , 1992, American journal of human genetics.

[16]  M. Pericak-Vance,et al.  Linkage of Tunisian autosomal recessive Duchenne–like muscular dystrophy to the pericentromeric region of chromosome 13q , 1992, Nature Genetics.

[17]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.

[18]  K. Campbell,et al.  Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy , 1992, Nature.

[19]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). , 1993, The Journal of biological chemistry.

[20]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[21]  K. Campbell,et al.  Deficiency of the 50 kDa dystrophin associated glycoprotein (adhalin) in severe autosomal recessive muscular dystrophies in children native from European countries. , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[22]  J. Ervasti,et al.  Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. , 1993, The Journal of biological chemistry.

[23]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Carbonetto,et al.  Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. , 1993, The Journal of biological chemistry.

[25]  K. Campbell,et al.  Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysis. , 1993, Human molecular genetics.

[26]  M. F. Peters,et al.  Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution , 1993, Neuron.

[27]  M. Shigekawa,et al.  Defective association of dystrophin with sarcolemmal glycoproteins in the cardiomyopathic hamster heart , 1993, FEBS letters.

[28]  K. Campbell,et al.  Congenital muscular dystrophy with merosin deficiency. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[29]  J. Beckmann,et al.  Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy , 1994, Cell.

[30]  K. Campbell,et al.  Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiency. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[31]  V. Dubowitz,et al.  Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. , 1994, Human molecular genetics.

[32]  H. Yamamoto,et al.  Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. , 1994, European journal of biochemistry.

[33]  K. Bushby,et al.  A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2p. , 1994, Human molecular genetics.

[34]  Victor V. Solovyev,et al.  Predicting alpha-helix and beta-strand segments of globular proteins , 1994, Comput. Appl. Biosci..

[35]  O. Ibraghimov-Beskrovnaya,et al.  Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. , 1994, The Journal of biological chemistry.

[36]  I. Nonaka,et al.  Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle. , 1994, Biochemical and biophysical research communications.

[37]  K. Bushby.  Diagnostic criteria for the limb-girdle muscular dystrophies: Report of the ENMC consortium on limbgirdle dystrophies , 1995, Neuromuscular Disorders.

[38]  J. Beckmann,et al.  β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12 , 1995, Nature Genetics.

[39]  J. Beckmann,et al.  Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity , 1995, Nature Genetics.

[40]  K. Aldape,et al.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.

[41]  S. Noguchi,et al.  Dystrophin-associated proteins in muscular dystrophy. , 1995, Human molecular genetics.

[42]  [Severe childhood autosomal recessive muscular dystrophy]. , 1995, Rinsho shinkeigaku = Clinical neurology.

[43]  I. Nonaka,et al.  Sarcoglycan complex is selectively lost in dystrophic hamster muscle. , 1995, The American journal of pathology.

[44]  J. Beckmann,et al.  30th and 31st ENMC international workshops, Naarden, The Netherlands, Held 6–8 January 1995 , 1995, Neuromuscular Disorders.

[45]  L. Kunkel,et al.  Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy , 1995, Science.

[46]  M. Passos-Bueno,et al.  Confirmation of the 2p locus for the mild autosomal recessive limb-girdle muscular dystrophy gene (LGMD2B) in three families allows refinement of the candidate region. , 1995, Genomics.

[47]  J. Stajich,et al.  Evidence for locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy. , 1995, American journal of human genetics.

[48]  Isabelle Richard,et al.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.

[49]  K. Campbell,et al.  Identification and Characterization of the Dystrophin Anchoring Site on β-Dystroglycan (*) , 1995, The Journal of Biological Chemistry.

[50]  L. Kunkel,et al.  β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex , 1995, Nature Genetics.

[51]  J. Beckmann,et al.  The limb-girdle muscular dystrophies--proposal for a new nomenclature. , 1995, Neuromuscular disorders : NMD.

[52]  K. Campbell,et al.  A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy. , 1995, Human molecular genetics.

[53]  L. Kunkel,et al.  Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin , 1995, Annals of neurology.

[54]  K. Campbell.  Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage , 1995, Cell.

[55]  L. Kunkel,et al.  Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). , 1996, Human molecular genetics.

[56]  E. Hoffman,et al.  Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex , 1996, Neuromuscular Disorders.

[57]  L. Kunkel,et al.  The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. , 1996, Human molecular genetics.

[58]  M. F. Peters,et al.  Isoform Diversity of Dystrobrevin, the Murine 87-kDa Postsynaptic Protein (*) , 1996, The Journal of Biological Chemistry.

[59]  L. Kunkel,et al.  Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. , 1996, Human molecular genetics.

[60]  K. Campbell,et al.  Absence of γ‐sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12 , 1996, FEBS letters.

[61]  J. Weissenbach,et al.  Genetic and physical mapping at the limb-girdle muscular dystrophy locus (LGMD2B) on chromosome 2p. , 1996, Genomics.

[62]  M. Lisanti,et al.  Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[63]  J. Ervasti,et al.  A new model for the interaction of dystrophin with F-actin , 1996, The Journal of cell biology.

[64]  L. Kunkel,et al.  Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. , 1996, American journal of human genetics.

[65]  M. Passos-Bueno,et al.  Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. , 1996, Nature genetics.

[66]  M. Passos-Bueno,et al.  Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene , 1996, Nature Genetics.

[67]  K. Campbell,et al.  Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. , 1996, The New England journal of medicine.

[68]  J. McPherson,et al.  Characterization of δ-Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy* , 1996, The Journal of Biological Chemistry.

[69]  M. Passos-Bueno,et al.  Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD. , 1996, Human molecular genetics.

[70]  J. Beckmann,et al.  A founder mutation in the gamma-sarcoglycan gene of gypsies possibly predating their migration out of India. , 1996, Human molecular genetics.

[71]  G. Viglietto,et al.  Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. , 1996, Human molecular genetics.

[72]  K. Campbell,et al.  Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.

[73]  L. Kunkel,et al.  Dystrophies and heart disease. , 1997, Current opinion in cardiology.

[74]  Y. Hayashizaki,et al.  Identification of the Syrian hamster cardiomyopathy gene. , 1997, Human molecular genetics.

[75]  J. Ervasti,et al.  Dystrophin-Glycoprotein Complex Is Monomeric and Stabilizes Actin Filaments in Vitro through a Lateral Association* , 1997, The Journal of Biological Chemistry.

[76]  E. Hoffman,et al.  Mutations in the δ-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2) , 1997, Neurogenetics.

[77]  K. Campbell,et al.  Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex* , 1997, The Journal of Biological Chemistry.

[78]  M. Passos-Bueno,et al.  The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. , 1997, American journal of human genetics.

[79]  N. Nardocci,et al.  Concomitant deficiency of beta- and gamma-sarcoglycans in 20 alpha-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects. , 1997, Acta neuropathologica.

[80]  E. Hoffman,et al.  Mutations in the sarcoglycan genes in patients with myopathy. , 1997, The New England journal of medicine.

[81]  L. Kunkel,et al.  Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[82]  E. McNally,et al.  Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. , 1997, American journal of human genetics.

[83]  Y. Murakami,et al.  Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[84]  K. Arimura,et al.  New missense mutation in the alpha-sarcoglycan gene in a Japanese patient with severe childhood autosomal recessive muscular dystrophy with incomplete alpha-sarcoglycan deficiency , 1997, Journal of the Neurological Sciences.

[85]  J. Sanes,et al.  ε-Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2D* , 1997, The Journal of Biological Chemistry.

[86]  N. Nardocci,et al.  Concomitant deficiency of β- and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects , 1997, Acta Neuropathologica.

[87]  K. Campbell,et al.  Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. , 1997, Neurology.

[88]  K. Davies.  Challenges in Duchenne muscular dystrophy 1 This review is based on the first Alan Emery lecture given at Green College, Oxford, on 11th March 1997. 1 , 1997, Neuromuscular Disorders.

[89]  Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). , 1997, Journal of medical genetics.

[90]  S. Thibodeau,et al.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. , 1998, Science.

[91]  John A. Faulkner,et al.  Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice , 1998, The Journal of cell biology.

[92]  K. Campbell,et al.  Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. , 1998, Molecular cell.

[93]  P. Jongen,et al.  The heart in limb girdle muscular dystrophy , 1998, Heart.

[94]  C. Bönnemann,et al.  LGMD 2E in Tunisia is caused by a homozygous missense mutation in β-sarcoglycan exon 3 , 1998, Neuromuscular Disorders.

[95]  J. Towbin,et al.  The role of cytoskeletal proteins in cardiomyopathies. , 1998, Current opinion in cell biology.

[96]  C. Greenberg,et al.  A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. , 1998, American journal of human genetics.

[97]  C. Leveille,et al.  Animal Model Molecular Pathogenesis of Muscle Degeneration in the d-Sarcoglycan-Deficient Hamster , 1998 .

[98]  K. Campbell,et al.  Caveolin‐3 is not an integral component of the dystrophin glycoprotein complex , 1998, FEBS letters.

[99]  F. Zara,et al.  Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy , 1998, Nature Genetics.

[100]  L. Kunkel,et al.  Human ϵ‐sarcoglycan is highly related to α‐sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene 1 , 1998, FEBS letters.

[101]  L. Kunkel,et al.  Caveolin-3 in muscular dystrophy. , 1998, Human molecular genetics.

[102]  E. Hoffman,et al.  Homozygous α‐sarcoglycan mutation in two siblings: One asymptomatic and one steroid‐responsive mild limb–girdle muscular dystrophy patient , 1998, Muscle & nerve.

[103]  F. Quétier,et al.  β-Sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate , 1998, Neuromuscular Disorders.

[104]  S. Noguchi,et al.  From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy , 1998, Muscle & nerve.

[105]  Human adhalin is alternatively spliced and the gene is located on chromosome 17 q 21 ( musular dystrophy / dystrophin / dystrophn-ated protein ) , .